News-Medical.Net on MSN
SolasCure completes phase II clinical trial, demonstrating accelerated healing with Aurase Wound Gel
SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the successful completion of its second Phase II clinical trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results